Cargando…

Human Genetics to Identify Therapeutic Targets for NAFLD: Challenges and Opportunities

Non-alcoholic fatty liver disease (NAFLD) is a continuous progression of pathophysiologic stages that is challenging to diagnose due to its inherent heterogeneity and poor standardization across a wide variety of diagnostic measures. NAFLD is heritable, and several loci have been robustly associated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Du, Xiaomi, DeForest, Natalie, Majithia, Amit R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688763/ https://www.ncbi.nlm.nih.gov/pubmed/34950105 http://dx.doi.org/10.3389/fendo.2021.777075

Ejemplares similares

Genetics of Type 2 Diabetes: Implications from Large-Scale Studies
por: DeForest, Natalie, et al.
Publicado: (2022)

Editorial: Secreted proteins as novel biomarkers and therapeutic targets in NAFLD
por: Xiong, Xuelian
Publicado: (2023)

Immunotherapy for NAFLD and NAFLD-related hepatocellular carcinoma
por: Jeong, Seogsong, et al.
Publicado: (2023)

Comprehensive Analysis of NAFLD and the Therapeutic Target Identified
por: Wen, Weiheng, et al.
Publicado: (2021)

Identifying the challenges and opportunities of PCOS awareness month by analysing its global digital impact
por: Malhotra, Kashish, et al.
Publicado: (2023)

Editorial: The NAFLD-MAFLD conundrum
por: Dalbeni, Andrea, et al.
Publicado: (2023)

Using proteomics and metabolomics to identify therapeutic targets for senescence mediated cancer: genetic complementarity method
por: Fang, Xiaolu, et al.
Publicado: (2023)

Editorial: Cross-talk and interaction between endocrinology and urology: challenges and opportunities
por: Song, Yuxuan, et al.
Publicado: (2023)

Regulation of Mammalian Mitochondrial Dynamics: Opportunities and Challenges
por: Yu, Rong, et al.
Publicado: (2020)

Human gain-of-function variants in HNF1A confer protection from diabetes but independently increase hepatic secretion of atherogenic lipoproteins
por: DeForest, Natalie, et al.
Publicado: (2023)

Circulating Ism1 Reduces the Risk of Type 2 Diabetes but not Diabetes-Associated NAFLD
por: Wang, Jiajia, et al.
Publicado: (2022)

Sensitivity to Thyroid Hormone Indices Are Closely Associated With NAFLD
por: Lai, Shuiqing, et al.
Publicado: (2021)

Editorial: Pharmacology and treatment methods for NAFLD in the context of diabetes
por: Abu-Farha, Mohamed, et al.
Publicado: (2022)

Major roles of kupffer cells and macrophages in NAFLD development
por: Park, Soo-Jeung, et al.
Publicado: (2023)

Comparative Study of Different Diets-Induced NAFLD Models of Zebrafish
por: Chen, Bo, et al.
Publicado: (2018)

Cardiovascular and renal burdens among patients with MAFLD and NAFLD in China
por: Wang, Yuying, et al.
Publicado: (2022)

Semaglutide ameliorates metabolism and hepatic outcomes in an NAFLD mouse model
por: Niu, Shu, et al.
Publicado: (2022)

Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)
por: Rong, Li, et al.
Publicado: (2023)

The role of FOXA family transcription factors in glucolipid metabolism and NAFLD
por: Yu, Chuchu, et al.
Publicado: (2023)

The mechanisms crosstalk and therapeutic opportunities between ferroptosis and ovary diseases
por: Yao, Ying, et al.
Publicado: (2023)

Vitamin D improves hepatic steatosis in NAFLD via regulation of fatty acid uptake and β-oxidation
por: Du, Tingwan, et al.
Publicado: (2023)

Comprehensive Transcriptome Profiling of NAFLD- and NASH-Induced Skeletal Muscle Dysfunction
por: Guo, Mingwei, et al.
Publicado: (2022)

Crucial role of T cells in NAFLD-related disease: A review and prospect
por: Mao, Tianyu, et al.
Publicado: (2022)

Hunger & satiety signals: another key mechanism involved in the NAFLD pathway
por: López-Méndez, Iván, et al.
Publicado: (2023)

Editorial: Application of telehealth to diabetes care delivery and medical training: challenges and opportunities
por: Middelbeek, Roeland J. W., et al.
Publicado: (2023)

Research Perspectives on the Regulation and Physiological Functions of FGF21 and its Association with NAFLD
por: Inagaki, Takeshi
Publicado: (2015)

Pathophysiology of NAFLD and NASH in Experimental Models: The Role of Food Intake Regulating Peptides
por: Kořínková, L., et al.
Publicado: (2020)

Serum metabolomic profiling unveils distinct sex-related metabolic patterns in NAFLD
por: Fotakis, Charalambos, et al.
Publicado: (2023)

In vitro beta-cell killing models using immune cells and human pluripotent stem cell-derived islets: Challenges and opportunities
por: Halliez, Clémentine, et al.
Publicado: (2023)

Analysis of Compound Postsynaptic Potentials in the Central Nervous System of the Surf Clam
por: Mellon, DeForest
Publicado: (1967)

Electrophysiological Evidence for Intrinsic Pacemaker Currents in Crayfish Parasol Cells
por: Mellon, DeForest
Publicado: (2016)

MBOAT7 rs641738 (C>T) is associated with NAFLD progression in men and decreased ASCVD risk in elder Chinese population
por: Xu, Xiaoyi, et al.
Publicado: (2023)

Glycocalyx engineering with heparan sulfate mimetics attenuates Wnt activity during adipogenesis to promote glucose uptake and metabolism
por: Trieger, Greg W., et al.
Publicado: (2023)

Too Much of a Good Thing? An Evolutionary Theory to Explain the Role of Ceramides in NAFLD
por: Poss, Annelise M., et al.
Publicado: (2020)

Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis
por: Lian, Jingxuan, et al.
Publicado: (2021)

Exploration of the core gene signatures and mechanisms between NAFLD and sarcopenia through transcriptomic level
por: Xu, Ziying, et al.
Publicado: (2023)

Glucokinase regulatory protein: a balancing act between glucose and lipid metabolism in NAFLD
por: Zhang, Ziqi, et al.
Publicado: (2023)

Is MG53 a potential therapeutic target for cancer?
por: Du, Yunyu, et al.
Publicado: (2023)

OR22-07 Novel Variants in Protein Kinase a Signaling-Related Genes Identified in Obese Children with and Without NAFLD
por: Bloyd, Michelle, et al.
Publicado: (2020)

Network Pharmacology and Bioinformatics Analysis Identifies Potential Therapeutic Targets of Paxlovid Against LUAD/COVID-19
por: Zhang, Wentao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q79acouqipt32j2jhqgihsbvm5